Related Experiment Video
Updated: Nov 8, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
The Role of Cholesterol Homeostasis in Diabetic Kidney Disease
Xinyun Chen1, Qinghua Yin1, Liang Ma1
1Kidney Research Institute, Division of Nephrology, West China Hospital of Sichuan University, Chengdu 610041, China.
Abstract:
Considerable evidence has proved that disturbed cholesterol metabolism played a crucial role in diabetic kidney disease. Besides, massive cholesterol depositions were found in intrinsic renal cells of diabetic kidney disease patients and animal models, causing cytotoxicity and affecting renal function. Statins could alleviate cholesterol depositions, podocyte injury, and microalbuminuria of diabetic kidney disease. In this review, we summarized the process of disturbed cholesterol metabolism and discussed how it induced kidney dysfunction in diabetic kidney disease.
Insights
Disturbed cholesterol metabolism is key in diabetic kidney disease, leading to cell damage and impaired kidney function. Statins show promise in alleviating these effects and protecting the kidneys.
Area of Science:
- Nephrology
- Metabolic Disorders
- Pharmacology
Background:
- Diabetic kidney disease (DKD) is a major complication of diabetes.
- Disturbed cholesterol metabolism is increasingly recognized as a significant factor in DKD pathogenesis.
- Accumulation of cholesterol in renal cells contributes to cytotoxicity and functional decline in DKD.
Purpose of the Study:
- To review the mechanisms of disturbed cholesterol metabolism in diabetic kidney disease.
- To discuss the role of cholesterol deposition in inducing kidney dysfunction.
- To highlight the therapeutic potential of statins in managing DKD.
Main Methods:
- Literature review of studies on cholesterol metabolism and diabetic kidney disease.
- Analysis of evidence linking cholesterol deposition to renal cell damage.
- Examination of the effects of statins on DKD markers.
Main Results:
- Evidence confirms disturbed cholesterol metabolism as a critical driver of DKD.
- Cholesterol accumulation in intrinsic renal cells causes cytotoxicity and impairs kidney function.
- Statins demonstrate potential in reducing cholesterol deposition, podocyte injury, and microalbuminuria in DKD.
Conclusions:
- Understanding cholesterol metabolism is vital for DKD management.
- Targeting cholesterol pathways may offer therapeutic benefits for diabetic kidney disease patients.
- Statins represent a promising therapeutic strategy for mitigating DKD progression.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Introduction to Urinary System
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

